NCT05126719 2026-02-06A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal CarcinomaShanghai Miracogen Inc.Phase 2 Active not recruiting238 enrolled